Literature DB >> 24631946

Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies.

F Turati1, C Galeone1, M Rota2, C Pelucchi3, E Negri1, V Bagnardi4, G Corrao5, P Boffetta6, C La Vecchia7.   

Abstract

Despite several studies support a positive association between heavy alcohol consumption and liver cancer risk, a consistent dose-risk relationship has not yet been established. We carried out a systematic review and a meta-analysis of the association between alcohol intake and liver cancer occurrence, following the Meta-analysis Of Observational Studies in Epidemiology guidelines. We searched for cohort and nested case-control studies on the general population published before April 2013, using PubMed and EMBASE. Summary meta-analytic relative risks (RRs) were estimated using random-effect models. We included 16 articles (19 cohorts) for a total of 4445 incident cases and 5550 deaths from liver cancer. Compared with non-drinking, the pooled RRs were 0.91 (95% confidence interval, CI, 0.81-1.02) for moderate drinking (< 3 drinks per day) and 1.16 (95% CI, 1.01-1.34) for heavy drinking (≥ 3 drinks per day), with significant heterogeneity among studies. The dose-risk curve suggested a linear relationship with increasing alcohol intake in drinkers, with estimated excess risk of 46% for 50 g of ethanol per day and 66% for 100 g per day. This systematic review suggests a moderate detrimental role of consumption of 3 or more alcoholic drinks per day on liver cancer, and a lack of association with moderate drinking. Our results have to be taken with due caution on account of the possible limitations of the original studies included in the meta-analysis.
© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  alcohol; epidemiology; liver cancer; meta-analysis; risk factors; systematic review

Mesh:

Year:  2014        PMID: 24631946     DOI: 10.1093/annonc/mdu020

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  55 in total

1.  Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.

Authors:  Nicole M Niehoff; Emily C Zabor; Jaya Satagopan; Anders Widell; Thomas R O'Brien; Mingdong Zhang; Nathaniel Rothman; Tom K Grimsrud; Stephen K Van Den Eeden; Lawrence S Engel
Journal:  Environ Res       Date:  2020-05-20       Impact factor: 6.498

Review 2.  Pesticide exposure and liver cancer: a review.

Authors:  Trang VoPham; Kimberly A Bertrand; Jaime E Hart; Francine Laden; Maria M Brooks; Jian-Min Yuan; Evelyn O Talbott; Darren Ruddell; Chung-Chou H Chang; Joel L Weissfeld
Journal:  Cancer Causes Control       Date:  2017-02-13       Impact factor: 2.506

Review 3.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

4.  Health behaviors of Korean adults with hepatitis B: Findings of the 2016 Korean National Health and Nutrition Examination Survey.

Authors:  Yu-Hyeon Yi; Yun-Jin Kim; Sang-Yeoup Lee; Byung-Mann Cho; Young-Hye Cho; Jeong-Gyu Lee
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 5.  AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.

Authors:  Rohit Loomba; Joseph K Lim; Heather Patton; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2020-01-30       Impact factor: 22.682

6.  The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.

Authors:  Patricia D Jones; Carlos Diaz; Danlu Wang; Joselin Gonzalez-Diaz; Paul Martin; Erin Kobetz
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

7.  Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Authors:  Saleh A Alqahtani; Faisal M Sanai; Ashwaq Alolayan; Faisal Abaalkhail; Hamad Alsuhaibani; Mazen Hassanain; Waleed Alhazzani; Abdullah Alsuhaibani; Abdullah Algarni; Alejandro Forner; Richard S Finn; Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2020-10       Impact factor: 2.485

Review 8.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Authors:  Katherine A McGlynn; Jessica L Petrick; W Thomas London
Journal:  Clin Liver Dis       Date:  2015-02-26       Impact factor: 6.126

Review 9.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

Review 10.  Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Avik Majumdar; Davide Roccarina; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.